ArticleCancers2022

Interventional Oncolytic Immunotherapy with LTX-315 for Residual Tumor after Incomplete Radiofrequency Ablation of Liver Cancer.

Guanhui Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.